Tov Elpis

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• DIETARYLBL1 refused line

  Not identified as a dietary supplement

  The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Tov Elpis

Is Tov Elpis on an FDA import alert?

No listing for Tov Elpis appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the Ukraine page.

Has FDA refused shipments from Tov Elpis?

Yes. FDA refused 2 shipment lines from Tov Elpis between December 23, 2025 and July 15, 2026. The most recent, on July 15, 2026, was herbals & botanicals (not teas), n.e.c., charged as DIETARYLBL (not identified as a dietary supplement).

Why did FDA refuse Tov Elpis's shipments?

The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 1 line) and NCONTACT (no u.s. adverse event contact on supplement label, 1 line).

What is Tov Elpis's FEI number?

Tov Elpis's FDA Establishment Identifier (FEI) is 3018594299.